Hana Must SPAC 2 (208370) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Hana Must SPAC 2 (208370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩838.06 Million ≈ $567.94K USD) by net assets (₩63.95 Billion ≈ $43.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 208370 net asset quality score to measure how much of total assets are equity-financed.

Hana Must SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Hana Must SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hana Must SPAC 2 (208370) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Hana Must SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Must SPAC 2 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Makina Takim Endustrisi AS
IS:MAKTK
-0.038x
Frasers Group PLC
LSE:FRAS
0.058x
Woori SPAC 3
KQ:198440
0.050x
Surapon Foods Public Company Limited
BK:SSF
0.082x
BANXA HOLDINGS INC.
F:AC00
N/A
Arianne Phosphate Inc
V:DAN
-0.019x
Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA
F:MUT3
0.033x
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
-0.003x

Annual Cash Flow Conversion Efficiency for Hana Must SPAC 2 (2015–2024)

The table below shows the annual cash flow conversion efficiency of Hana Must SPAC 2 from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Hana Must SPAC 2.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩63.80 Billion
≈ $43.24 Million
₩4.50 Billion
≈ $3.05 Million
0.071x +22.09%
2023-12-31 ₩60.10 Billion
≈ $40.73 Million
₩3.47 Billion
≈ $2.35 Million
0.058x +3640.27%
2022-12-31 ₩32.89 Billion
≈ $22.29 Million
₩50.81 Million
≈ $34.43K
0.002x -98.52%
2021-12-31 ₩28.06 Billion
≈ $19.02 Million
₩2.93 Billion
≈ $1.98 Million
0.104x -38.53%
2020-12-31 ₩24.89 Billion
≈ $16.87 Million
₩4.23 Billion
≈ $2.86 Million
0.170x +11.18%
2019-12-31 ₩24.14 Billion
≈ $16.36 Million
₩3.69 Billion
≈ $2.50 Million
0.153x +132.33%
2018-12-31 ₩14.60 Billion
≈ $9.90 Million
₩-6.90 Billion
≈ $-4.67 Million
-0.472x -205.32%
2017-12-31 ₩27.81 Billion
≈ $18.85 Million
₩-4.30 Billion
≈ $-2.92 Million
-0.155x +33.13%
2016-12-31 ₩26.92 Billion
≈ $18.24 Million
₩-6.23 Billion
≈ $-4.22 Million
-0.231x -2788.35%
2015-12-31 ₩19.09 Billion
≈ $12.94 Million
₩164.29 Million
≈ $111.33K
0.009x --

About Hana Must SPAC 2

KQ:208370 Korea Medical Devices
Market Cap
$43.31 Million
₩63.91 Billion KRW
Market Cap Rank
#22395 Global
#1393 in Korea
Share Price
₩2485.00
Change (1 day)
+4.41%
52-Week Range
₩2185.00 - ₩6650.00
All Time High
₩12885.20
About

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more